173 related articles for article (PubMed ID: 17847177)
1. Antibacterial treatment strategies in hospitalized patients: what role for pharmacoeconomics?
Goldman MP; Nair R
Cleve Clin J Med; 2007 Aug; 74 Suppl 4():S38-47. PubMed ID: 17847177
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in Slovenia.
Peklar J; Tratar F; Mrhar A
Pharm World Sci; 2004 Dec; 26(6):361-5. PubMed ID: 15683107
[No Abstract] [Full Text] [Related]
3. Econotherapeutics.
Roark MK; Reed WE
Diagn Microbiol Infect Dis; 1995; 22(1-2):209-17. PubMed ID: 7587042
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomics and formulary decision making.
Sanchez LA
Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
[TBL] [Abstract][Full Text] [Related]
5. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomics of antibacterial treatment.
Davey PG; Malek MM; Parker SE
Pharmacoeconomics; 1992 Jun; 1(6):409-37. PubMed ID: 10147022
[TBL] [Abstract][Full Text] [Related]
7. A team approach to hospital formulary replacement.
Lee J; Carlson JA; Chamberlain MA
Diagn Microbiol Infect Dis; 1995; 22(1-2):239-42. PubMed ID: 7587047
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacoeconomics].
Shiragami M
Yakugaku Zasshi; 2003 Mar; 123(3):133-42. PubMed ID: 12693013
[TBL] [Abstract][Full Text] [Related]
9. Clindamycin formulary restriction lowers costs, antimicrobial resistance.
Am J Health Syst Pharm; 1998 Aug; 55(15):1552. PubMed ID: 9706176
[No Abstract] [Full Text] [Related]
10. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics and the formulary decision-making process.
Bakst A
Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
[TBL] [Abstract][Full Text] [Related]
12. Use and misuse of pharmacoeconomic terms: a definitions primer.
Sanchez LA; Lee J
Top Hosp Pharm Manage; 1994 Jan; 13(4):11-22. PubMed ID: 10184005
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomics of appropriate antimicrobial use.
Davey P
Diagn Microbiol Infect Dis; 1995; 22(1-2):225-9. PubMed ID: 7587044
[TBL] [Abstract][Full Text] [Related]
14. Incorporating pharmacoeconomic principles into hospital pharmacy practice.
Gouveia WA; Bungay KM
Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681
[TBL] [Abstract][Full Text] [Related]
15. Economic impact and formulary positioning of linezolid: a new anti-Gram-positive antimicrobial.
Nathwani D
J Hosp Infect; 2001 Dec; 49 Suppl A():S33-41. PubMed ID: 11926439
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic aspects and formulary considerations related to histamine2-receptor antagonists.
Souney PF; Stoukides CA
DICP; 1989 Oct; 23(10 Suppl):S29-35. PubMed ID: 2573207
[TBL] [Abstract][Full Text] [Related]
17. The driving force in hospital formularies: economics versus efficacy.
Franklin GA
Am J Surg; 2003 Nov; 186(5A):55S-60S; discussion 60S-64S. PubMed ID: 14684227
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer TL
Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
[TBL] [Abstract][Full Text] [Related]
19. Cost of hospital antimicrobial chemotherapy. A method for global cost calculation.
Gyssens IC; Lennards CA; Hekster YA; Van der Meer JW
Pharm Weekbl Sci; 1991 Dec; 13(6):248-53. PubMed ID: 1795935
[TBL] [Abstract][Full Text] [Related]
20. Drug cost management in pharmacy management based on pharmacoeconomics: Antimicrobial treatment cases.
Liu S; He L; Sun L; Wang Y
Pak J Pharm Sci; 2017 May; 30(3(Special)):1069-1073. PubMed ID: 28671083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
